StonvexLoading…
StonvexStonvexStonvexCore line items from BSY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.50B | $1.35B | $1.23B | $1.10B |
Operating Income | $362.62M | $302.15M | $230.54M | $208.61M |
Net Income | $277.86M | $234.79M | $326.79M | $174.78M |
EPS (Diluted) | $0.85 | $0.72 | $1.00 | $0.55 |
Total Assets | $3.56B | $3.40B | $3.32B | $3.17B |
Total Liabilities | $2.37B | $2.36B | $2.44B | $2.59B |
Cash & Equivalents | $123.28M | $64.01M | $68.41M | $71.68M |
Free Cash Flow OCF − CapEx | $520.21M | $421.25M | $391.69M | $255.78M |
Shares Outstanding | 333.09M | 333.77M | 332.50M | 331.77M |